Highlights from Day 2 of the ESC 2021 congress – MASTER DAPT

Presented by Dr. Marco Valgimigli, the MASTER DAPT trial assessed whether 1 month of dual antiplatelet therapy (DAPT) following percutaneous coronary intervention (PCI), with a…

View More Highlights from Day 2 of the ESC 2021 congress – MASTER DAPT
Procedure

Current use and safety of novel oral anticoagulants in adults with congenital heart disease: results of a nationwide analysis including more than 44,000 patients

Dr Amit Bhan examines a study on Novel Oral Anticoagulants recently published in the European Heart Journal.

View More Current use and safety of novel oral anticoagulants in adults with congenital heart disease: results of a nationwide analysis including more than 44,000 patients